Breast cancer
A study to evaluate the effectiveness of a new chemotherapy regimen for breast cancer comparing to the standard chemotherapy.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Registry summary (technical)
A randomized, open-label, phase II study to evaluate the efficacy and safety of a novel dose-dense regimen of docetaxel-cyclophosphamide alternating with epirubicin-cisplatin compared to standard dose-dense anthracycline, taxane and cyclophosphamide as neoadjuvant chemotherapy in early and locally advanced TNBC. - NeoPlaNET
Sponsor: CMC Vellore
CTRI/2023/05/052756 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 8 Dec 2025 · read by us 5 Nov 2026